Browsing: News

This article was written byFollowJiangwei Li is a professional investor with more than 15 years of experience across business operations,…

Renaissance Capital provides pre-IPO research to institutional investors and investment banks. The Firm manages two IPO-focused funds: The Renaissance IPO…

Shinichiro FunabikiPresident, Group CEO & Representative Director [Interpreted] Thank you very much for joining us here in New York for…

This article was written byFollowI’m an independent equity trader and licensed financial advisor focused on uncovering high-upside opportunities in overlooked…

This article was written byFollowOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround…

This article was written byFollowArbitrage Trader, aka Denislav Iliev has been day trading for 15+ years and leads a team…

This article was written byFollowChris Lau is an individual investor and economist with 30 years of experience covering life science,…

Operator Ladies and gentlemen, thank you for standing by. Welcome to the New Horizon Aircraft Fiscal First Quarter 2027 Earnings…

Follow Teva Pharmaceutical Industries Limited (TEVA) Discusses FDA Approval of Weltruza and Strategic Growth Initiatives October 9, 2026 8:00 AM…

This article was written byFollowAfter 43+ years working for one investment research company or another, I finally retired. So now,…